Doody RS

General

Full name : Doody Rachelle S

First name : Rachelle S

Mail : Department of Neurology, Alzheimer's Disease and Memory Disorders Center, Baylor College of Medicine, Houston, TX 07730

Zip Code :

City :

Country : USA

Email : rdoody@bcm.edu

Phone :

Fax :

Website :

Directory :

References (22)

Title : Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease - Bateman_2022_Alzheimers.Res.Ther_14_178
Author(s) : Bateman RJ , Cummings J , Schobel S , Salloway S , Vellas B , Boada M , Black SE , Blennow K , Fontoura P , Klein G , Assuncao SS , Smith J , Doody RS
Ref : Alzheimers Res Ther , 14 :178 , 2022
PubMedID: 36447240

Title : Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD) - Nave_2017_J.Alzheimers.Dis_58_1217
Author(s) : Nave S , Doody RS , Boada M , Grimmer T , Savola JM , Delmar P , Pauly-Evers M , Nikolcheva T , Czech C , Borroni E , Ricci B , Dukart J , Mannino M , Carey T , Moran E , Gilaberte I , Muelhardt NM , Gerlach I , Santarelli L , Ostrowitzki S , Fontoura P
Ref : J Alzheimers Dis , 58 :1217 , 2017
PubMedID: 28550255

Title : Effectiveness of antidementia drugs in delaying Alzheimer's disease progression - Rountree_2013_Alzheimers.Dement_9_338
Author(s) : Rountree SD , Atri A , Lopez OL , Doody RS
Ref : Alzheimers Dement , 9 :338 , 2013
PubMedID: 23102979

Title : Validity, significance, strengths, limitations, and evidentiary value of real-world clinical data for combination therapy in Alzheimer's disease: comparison of efficacy and effectiveness studies - Atri_2012_Neurodegener.Dis_10_170
Author(s) : Atri A , Rountree SD , Lopez OL , Doody RS
Ref : Neurodegener Dis , 10 :170 , 2012
PubMedID: 22327239

Title : Reviewing the role of donepezil in the treatment of Alzheimer's disease - Doody_2012_Curr.Alzheimer.Res_9_773
Author(s) : Doody RS , Cummings JL , Farlow MR
Ref : Curr Alzheimer Res , 9 :773 , 2012
PubMedID: 22175653

Title : Progress in understanding variability in cognitive responses to cholinesterase inhibitor treatment - Pavlik_2011_Alzheimers.Res.Ther_3_30
Author(s) : Pavlik VN , Doody RS
Ref : Alzheimers Res Ther , 3 :30 , 2011
PubMedID: 21999183

Title : Persistent treatment with cholinesterase inhibitors and\/or memantine slows clinical progression of Alzheimer disease - Rountree_2009_Alzheimers.Res.Ther_1_7
Author(s) : Rountree SD , Chan W , Pavlik VN , Darby EJ , Siddiqui S , Doody RS
Ref : Alzheimers Res Ther , 1 :7 , 2009
PubMedID: 19845950

Title : Donepezil treatment of patients with MCI: a 48-week randomized, placebo- controlled trial -
Author(s) : Crane PK , Doody RS
Ref : Neurology , 73 :1514 , 2009
PubMedID: 19884584

Title : Vitamin E use is associated with improved survival in an Alzheimer's disease cohort - Pavlik_2009_Dement.Geriatr.Cogn.Disord_28_536
Author(s) : Pavlik VN , Doody RS , Rountree SD , Darby EJ
Ref : Dementia & Geriatric Cognitive Disorders , 28 :536 , 2009
PubMedID: 20016184

Title : Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial - Doody_2009_Neurology_72_1555
Author(s) : Doody RS , Ferris SH , Salloway S , Sun Y , Goldman R , Watkins WE , Xu Y , Murthy AK
Ref : Neurology , 72 :1555 , 2009
PubMedID: 19176895

Title : Cholinesterase inhibitors and memantine: best practices -
Author(s) : Doody RS
Ref : CNS Spectr , 13 :34 , 2008
PubMedID: 18955960

Title : Recommendations for best practices in the treatment of Alzheimer's disease in managed care - Fillit_2006_Am.J.Geriatr.Pharmacother_4 Suppl A_S9
Author(s) : Fillit HM , Doody RS , Binaso K , Crooks GM , Ferris SH , Farlow MR , Leifer B , Mills C , Minkoff N , Orland B , Reichman WE , Salloway S
Ref : Am J Geriatr Pharmacother , 4 Suppl A :S9 , 2006
PubMedID: 17157793

Title : Refining treatment guidelines in Alzheimer's disease - Doody_2005_Geriatrics_Suppl_14
Author(s) : Doody RS
Ref : Geriatrics , Suppl :14 , 2005
PubMedID: 16025771

Title : Donepezil in vascular dementia: combined analysis of two large-scale clinical trials - Roman_2005_Dement.Geriatr.Cogn.Disord_20_338
Author(s) : Roman GC , Wilkinson DG , Doody RS , Black SE , Salloway SP , Schindler RJ
Ref : Dementia & Geriatric Cognitive Disorders , 20 :338 , 2005
PubMedID: 16192723

Title : Current treatments for Alzheimer's disease: cholinesterase inhibitors - Doody_2003_J.Clin.Psychiatry_64 Suppl 9_11
Author(s) : Doody RS
Ref : J Clin Psychiatry , 64 Suppl 9 :11 , 2003
PubMedID: 12934969

Title : Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease - Doody_2001_Arch.Neurol_58_427
Author(s) : Doody RS , Geldmacher DS , Gordon B , Perdomo CA , Pratt RD
Ref : Archives of Neurology , 58 :427 , 2001
PubMedID: 11255446

Title : Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease - Doody_2001_Dement.Geriatr.Cogn.Disord_12_295
Author(s) : Doody RS , Dunn JK , Clark CM , Farlow M , Foster NL , Liao T , Gonzales N , Lai E , Massman P
Ref : Dementia & Geriatric Cognitive Disorders , 12 :295 , 2001
PubMedID: 11351141

Title : Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology - Doody_2001_Neurology_56_1154
Author(s) : Doody RS , Stevens JC , Beck C , Dubinsky RM , Kaye JA , Gwyther L , Mohs RC , Thal LJ , Whitehouse PJ , DeKosky ST , Cummings JL
Ref : Neurology , 56 :1154 , 2001
PubMedID: 11342679

Title : Clinical benefits of a new piperidine-class AChE inhibitor - Doody_1999_Eur.Neuropsychopharmacol_9_S69
Author(s) : Doody RS
Ref : European Neuropsychopharmacology , 9 :S69 , 1999
PubMedID: 10332937

Title : Clinical profile of donepezil in the treatment of Alzheimer's disease - Doody_1999_Gerontology_45_23
Author(s) : Doody RS
Ref : Gerontology , 45 :23 , 1999
PubMedID: 9876215

Title : Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group - Rogers_1998_Arch.Intern.Med_158_1021
Author(s) : Rogers SL , Doody RS , Mohs RC , Friedhoff LT
Ref : Archives of Internal Medicine , 158 :1021 , 1998
PubMedID: 9588436

Title : A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group - Rogers_1998_Neurology_50_136
Author(s) : Rogers SL , Farlow MR , Doody RS , Mohs R , Friedhoff LT
Ref : Neurology , 50 :136 , 1998
PubMedID: 9443470